Edwards Lifesciences
Logotype for Edwards Lifesciences Corporation

Edwards Lifesciences (EW) investor relations material

Edwards Lifesciences 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Edwards Lifesciences Corporation
44th Annual J.P. Morgan Healthcare Conference summary12 Jan, 2026

Strategic vision and innovation

  • Focused on structural heart therapies, with ongoing investment in TAVR, TMTT, and surgical platforms to address unmet patient needs and drive next-generation innovation.

  • Expanding the portfolio to pioneer therapies for unaddressed patient groups, such as asymptomatic AS, mitral, tricuspid, and aortic regurgitation, representing significant growth opportunities.

  • Emphasizes a patient-focused culture and global reach, with over 16,000 employees in more than 100 countries.

  • Commitment to community impact and value creation across the healthcare ecosystem through regular innovation and evidence generation.

Product and clinical milestones

  • SAPIEN platform leads TAVR with best-in-class technologies; 2025 saw practice-changing evidence from EARLY TAVR and PARTNER 3 trials.

  • MODERATE trial results to be presented at TCT, marking a new era of proactive disease management.

  • TMTT portfolio now includes PASCAL, EVOQUE, and SAPIEN M3, enabling personalized care and targeting $2B in revenue by 2030.

  • Surgical platform continues to drive adoption of RESILIA tissue technology, with ongoing development of new therapies for patients with limited options.

Financial performance and outlook

  • Achieved high-end 2025 guidance with strong sales and EPS, supported by over $1B in R&D investment.

  • 2026 guidance projects 8%-10% sales growth, 15% EPS growth, and 150 basis points margin improvement.

  • Diversified growth now driven by TAVR, TMTT, and surgical, with TMTT expected to reach $2B by 2030 and overall company targeting 10% average annual growth.

  • Margin expansion supported by disciplined R&D and SG&A management, with continued aggressive investment in innovation.

NCD and asymptomatic AS TAVR volume impact
TMTT growth acceleration and patient segmentation
M&A strategy and external investment focus
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Edwards Lifesciences earnings date

Logotype for Edwards Lifesciences Corporation
Q4 202513 Feb, 2026
Edwards Lifesciences
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Edwards Lifesciences earnings date

Logotype for Edwards Lifesciences Corporation
Q4 202513 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Edwards Lifesciences Corporation is an innovative medical-device company, providing products in structural heart disease, and critical care and surgical monitoring that can improve healthcare worldwide. Our comprehensive portfolio includes devices for chronic total occlusions (CTO) repair and treatment of mitral valve disease (MVD). We also design and manufacture mechanical circulatory support devices, including the bioresorbable percutaneous ventricular assist device (BiVAD(TM)) used in advanced heart failure. Edwards Lifesciences Corporation is based in Irvine, California.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage